Concept Medical Enrolls First Patient in MAGICAL-SV IDE Trial, Expands Coronary Program Globally
Tampa (Florida) [USA], August 4: Concept Medical Inc., a global pioneer in drug-delivery technologies, today announced the enrollment of the first patient in the MAGICAL-SV (MAGIcTouch Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels) trial, a U.S. Investigational Device Exemption (IDE) study evaluating its MagicTouch sirolimus-coated balloon (SCB) for the treatment of…
